Research Topics
| Steven SinghSummaryCountry: USA Publications
| Collaborators
|
Detail Information
Publications
Implantable cardioverter defibrillator therapy and the need for concomitant antiarrhythmic drugsSteven Singh
Veterans Affairs Medical Center, Washington, DC 20422, USA
J Cardiovasc Pharmacol Ther 12:175-80. 2007....
Systematic electrocardioversion for atrial fibrillation and role of antiarrhythmic drugs: a substudy of the SAFE-T trialSteven N Singh
Department of Cardiology, Veterans Affairs Medical Center, Washington, DC 20422, USA
Heart Rhythm 6:152-5. 2009..Energy levels for electrocardioversion in atrial fibrillation (AF) have been empiric, and the influence of antiarrhythmic therapy compared with placebo is largely unknown...
Quality of life and exercise performance in patients in sinus rhythm versus persistent atrial fibrillation: a Veterans Affairs Cooperative Studies Program SubstudySteven N Singh
Department of Veterans Affairs Medical Center, Washington, DC 20422, USA
J Am Coll Cardiol 48:721-30. 2006..The purpose of this study was to determine quality of life (QOL) and exercise performance (EP) in patients with persistent atrial fibrillation (AF) converted to sinus rhythm (SR) compared with those remaining in or reverting to AF...
Trials of new antiarrhythmic drugs for maintenance of sinus rhythm in patients with atrial fibrillationSteven Singh
Veterans Affairs Center, Washington, USA
J Interv Card Electrophysiol 10:71-6. 2004..Tedisamil is a complex class 3 agent, blocking multiple channels. Piboserod is a selective 5-HT receptor antagonist that is being investigated in clinical trials...
Role of dofetilide in patients with atrial fibrillation. Insights from the Symptomatic Atrial Fibrillation Investigative Research on Dofetilide (SAFIRE-D) studySteven N Singh
VA Medical Center, Washington, DC 20422, USA
Card Electrophysiol Rev 7:225-8. 2003..Caution must be used when initiating dofetilide therapy to avoid torsade de pointes ventricular tachycardia, especially in patients with heart failure, hypertrophy, bradycardia and female gender...
Comparison of sotalol versus amiodarone in maintaining stability of sinus rhythm in patients with atrial fibrillation (Sotalol-Amiodarone Fibrillation Efficacy Trial [Safe-T])Steven N Singh
Division of Cardiology, Veterans Affairs Medical Center, Washington, DC 20422, USA
Am J Cardiol 92:468-72. 2003..SAFE-T had randomized 665 patients when enrollment terminated on October 31, 2001. Follow-up of patients continued until October 31, 2002, for a maximum period of 54 months and a minimum period of 12 months for all patients...
The burden and management of TIA and stroke in the Veterans Administration and Department of DefenseSteven N Singh
Veterans Affairs Medical Center, 50 Irving St NW, Washington, DC 20422, USA
Am J Manag Care 15:S185-92. 2009..In addition, the VA system avoids incentivizing physicians for performing medical services, and instead incentivizes quality of care, which may provide a further advantage for patients treated within that system...
A graded association of exercise capacity and all-cause mortality in males with high-normal blood pressurePeter Kokkinos
Veterans Affairs Medical Center, Washington, DC 20422, USA
Blood Press 18:261-7. 2009..Thus, we evaluated the association of exercise capacity and all-cause mortality in individuals with high-normal blood pressure...
Exercise capacity and mortality in hypertensive men with and without additional risk factorsPeter Kokkinos
Veterans Affairs Medical Center Cardiology Division, 50 Irving St, NW, Washington, DC 20422, USA
Hypertension 53:494-9. 2009..The increased risk imposed by low fitness and additional cardiovascular risk factors was eliminated by relatively small increases in exercise capacity and declined progressively with higher exercise capacity...
Blood pressure control among US veterans: a large multiyear analysis of blood pressure data from the Veterans Administration health data repositoryRoss D Fletcher
Veterans Affairs Medical Center, 50 Irving St NW, Washington, DC 20422, USA
Circulation 125:2462-8. 2012..This study was designed to assess improvement in blood pressure control over a 10-year period in a large cohort of patients in the Department of Veterans Affairs...
Exercise capacity and all-cause mortality in prehypertensive menPeter Kokkinos
Department of Cardiology, Veterans Affairs Medical Center, Washington, DC, USA
Am J Hypertens 22:735-41. 2009..Increased exercise capacity is associated with lower mortality risk, but little is known about its effects in prehypertensives. Thus, we evaluated the association between exercise capacity and all-cause mortality in prehypertensives...
Exercise capacity and all-cause mortality in African American and Caucasian men with type 2 diabetesPeter Kokkinos
Veterans Affairs Medical Center, Washington, DC, USA
Diabetes Care 32:623-8. 2009..The purpose of this study was to assess the association between exercise capacity and mortality in African Americans and Caucasians with type 2 diabetes and to explore racial differences regarding this relationship...
Exercise capacity and mortality in black and white menPeter Kokkinos
Veterans Affairs Medical Center Cardiology Department, 50 Irving St NW, Washington, DC 20422, USA
Circulation 117:614-22. 2008..Exercise capacity is inversely related to mortality risk in healthy individuals and those with cardiovascular diseases. This evidence is based largely on white populations, with little information available for blacks...
Exercise capacity and blood pressure associations with left ventricular mass in prehypertensive individualsPeter Kokkinos
Veterans Affairs Medical Center, Cardiology Division, Washington, DC 20422, USA
Hypertension 49:55-61. 2007....
Exercise capacity in atrial fibrillation: a substudy of the Sotalol-Amiodarone Atrial Fibrillation Efficacy Trial (SAFE-T)J Edwin Atwood
Cardiology Division, Walter Reed Army Medical Center, 6900 Georgia Ave NW, Washington, DC 20307, USA
Am Heart J 153:566-72. 2007..Therapy for chronic atrial fibrillation (AF) focuses on rate versus rhythm control, but little is known about the effects of common therapeutic interventions on exercise tolerance in AF...
Amiodarone versus sotalol for atrial fibrillationBramah N Singh
Department of Veterans Affairs Medical Center, West Los Angeles, Calif 90073, USA
N Engl J Med 352:1861-72. 2005..The optimal pharmacologic means to restore and maintain sinus rhythm in patients with atrial fibrillation remains controversial...
Intrathoracic impedance preceding ventricular tachyarrhythmia episodesHans J Moore
Washington Veterans Affairs Medical Center, Washington, DC, USA
Pacing Clin Electrophysiol 33:960-6. 2010..We hypothesized that VT/VF episodes are preceded by decreases in intrathoracic impedance. The goal was to identify the relationship of intrathoracic impedance measured by implanted cardioverter defibrillators to the occurrence of VT/VF...
Role of amiodarone or implantable cardioverter/defibrillator in patients with atrial fibrillation and heart failureSteven N Singh
Department of Veterans Affairs Medical Center, Washington, DC 20422, USA
Am Heart J 152:974.e7-11. 2006..Amiodarone is effective in reducing new AF, but not in converting AF to SR. Implantable cardioverter/defibrillator, inappropriate, and appropriate shocks were more often seen in AF than in SR...
Meta-analysis of antiarrhythmic therapy in the prevention of postoperative atrial fibrillation and the effect on hospital length of stay, costs, cerebrovascular accidents, and mortality in patients undergoing cardiac surgeryJennifer Zimmer
Department of Cardiology, Veterans Affairs Medical Center, Washington, DC 20422, USA
Am J Cardiol 91:1137-40. 2003
QRS duration and mortality in patients with congestive heart failureStephen Iuliano
Veterans Affairs and Georgetown University Medical Centers, Washington, DC 20422, USA
Am Heart J 143:1085-91. 2002..965). Age, type of cardiomyopathy, and drug treatment group were not predictive of mortality. CONCLUSION: QRS prolongation is an independent predictor of both increased total mortality and sudden death in patients with heart failure...
Nonsustained ventricular tachycardia in dilated cardiomyopathyFrank A Cuoco
Department of Cardiology, Veterans Affairs Medical Center, 4A107, 50 Irving Street, NW, Washington, DC 20422, USA
Curr Cardiol Rep 7:368-75. 2005..This article focuses on the prognostic significance and treatment of patients with NSVT and ischemic or nonischemic dilated cardiomyopathy...
Pseudoaneurysm of mitral-aortic intervalvular fibrosa: two case reports and review of literatureThaslim Ahamed Kassim
Department of Internal Medicine, Howard University Hospital, 2041 Georgia Avenue, NW, Washington, DC 20060, USA
Eur J Echocardiogr 11:E7. 2010..Pseudoaneurysm of the mitral-aortic intervalvular fibrosa is a rare complication of infective endocarditis, but delay in diagnosis can lead to devastating outcome...
Exercise capacity and 24-h blood pressure in prehypertensive men and womenPeter Kokkinos
Veterans Affairs Medical Center Cardiology Division, Washington, DC Georgetown University Medical Center, Washington, DC, USA
Am J Hypertens 19:251-8. 2006..Physically active, normotensive individuals are also at lower risk for developing hypertension than sedentary individuals. We assessed the relationship between fitness and 24-h ambulatory BP in prehypertensive men and women...
Thyroid function abnormalities during amiodarone therapy for persistent atrial fibrillationElizabeth L Batcher
West Los Angeles Veterans Affairs Medical Center, Los Angeles, Calif, USA
Am J Med 120:880-5. 2007..The purpose of this study was to determine the extent of amiodarone-induced thyroid dysfunction in a large male cohort...
Prognostic value of heart rate variability in chronic congestive heart failure (Veterans Affairs' Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure)Kenneth C Bilchick
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
Am J Cardiol 90:24-8. 2002..3 ms had a significantly increased risk of sudden death (p = 0.016). Thus, HRV was the sole independent predictor of overall mortality and was significantly associated with sudden death in this population...
The efficacy of azimilide in the treatment of atrial fibrillation in the presence of left ventricular systolic dysfunction: results from the Azimilide Postinfarct Survival Evaluation (ALIVE) trialCraig M Pratt
The Methodist DeBakey Heart Center and Department of Medicine, Section of Cardiology, Baylor College of Medicine, Houston, Texas 77030, USA
J Am Coll Cardiol 43:1211-6. 2004....
Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT)Aldo P Maggioni
ANMCO Research Center, Florence, Italy
Am Heart J 149:548-57. 2005..The aims of these subanalyses of Val-HeFT were to assess (a) the effects of valsartan in the prevention of AF, (b) the independent predictors of this event, and (c) the prognostic role of AF occurrence...
Vasopeptidase inhibition with omapatrilat in chronic heart failure: acute and long-term hemodynamic and neurohumoral effectsDougal R McClean
Christchurch Hospital, Christchurch, New Zealand
J Am Coll Cardiol 39:2034-41. 2002..After 12 weeks, the hemodynamic benefit was maintained. Omapatrilat may be a promising new agent in CHF...
